UNLEASH THERAPEUTICS Trademark
Trademark Overview
On Monday, September 27, 2021, a trademark application was filed for UNLEASH THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the UNLEASH THERAPEUTICS trademark a serial number of 97047436. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, May 30, 2023. This trademark is owned by Unleash Therapeutics, LLC. The UNLEASH THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
pharmaceutical products for the treatment of canine cancer, excluding pet food supplements
pharmaceutical research and development in the field of canine cancer, excluding pet food supplements
General Information
| Serial Number | 97047436 |
| Word Mark | UNLEASH THERAPEUTICS |
| Filing Date | Monday, September 27, 2021 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, May 30, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | pharmaceutical products for the treatment of canine cancer, excluding pet food supplements |
| Disclaimer with Predetermined Text | "THERAPEUTICS" |
| Goods and Services | pharmaceutical research and development in the field of canine cancer, excluding pet food supplements |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 27, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 27, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Unleash Therapeutics, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | San Francisco, CA 94114 |
Trademark Events
| Event Date | Event Description |
| Wednesday, May 31, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Tuesday, May 30, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Tuesday, May 30, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, February 8, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, February 8, 2023 | FINAL REFUSAL E-MAILED |
| Wednesday, February 8, 2023 | FINAL REFUSAL WRITTEN |
| Thursday, December 29, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 29, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 29, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 30, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 30, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, June 30, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, June 27, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, October 27, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 30, 2021 | NEW APPLICATION ENTERED |
